Ryan PB - Search Results

1

Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.

Chen R, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J, Pratt N, Reich CG, Madigan D, You SC, Ryan PB, Hripcsak G. Chen R, et al. Among authors: ryan pb. Hypertension. 2021 Sep;78(3):591-603. doi: 10.1161/HYPERTENSIONAHA.120.16667. Epub 2021 Jul 26. Hypertension. 2021. PMID: 34304580 Free PMC article.

2

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research.

Madigan D, Ryan P. Madigan D, et al. Epidemiology. 2011 Sep;22(5):629-31. doi: 10.1097/EDE.0b013e318228ca1d. Epidemiology. 2011. PMID: 21811110 No abstract available.

3

Disproportionality methods for pharmacovigilance in longitudinal observational databases.

Zorych I, Madigan D, Ryan P, Bate A. Zorych I, et al. Stat Methods Med Res. 2013 Feb;22(1):39-56. doi: 10.1177/0962280211403602. Epub 2011 Aug 30. Stat Methods Med Res. 2013. PMID: 21878461

4

Validation of a common data model for active safety surveillance research.

Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Overhage JM, et al. Among authors: ryan pb. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60. doi: 10.1136/amiajnl-2011-000376. Epub 2011 Oct 28. J Am Med Inform Assoc. 2012. PMID: 22037893 Free PMC article.

5

Novel data-mining methodologies for adverse drug event discovery and analysis.

Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Harpaz R, et al. Clin Pharmacol Ther. 2012 Jun;91(6):1010-21. doi: 10.1038/clpt.2012.50. Clin Pharmacol Ther. 2012. PMID: 22549283 Free PMC article. Review.

6

Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases.

Reich C, Ryan PB, Stang PE, Rocca M. Reich C, et al. Among authors: ryan pb. J Biomed Inform. 2012 Aug;45(4):689-96. doi: 10.1016/j.jbi.2012.05.002. Epub 2012 Jun 7. J Biomed Inform. 2012. PMID: 22683994 Free article.

7

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.

Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Ryan PB, et al. Stat Med. 2012 Dec 30;31(30):4401-15. doi: 10.1002/sim.5620. Epub 2012 Sep 27. Stat Med. 2012. PMID: 23015364

8

Evaluating the impact of database heterogeneity on observational study results.

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA. Madigan D, et al. Among authors: ryan pb. Am J Epidemiol. 2013 Aug 15;178(4):645-51. doi: 10.1093/aje/kwt010. Epub 2013 May 5. Am J Epidemiol. 2013. PMID: 23648805 Free PMC article.

9

Interpreting observational studies: why empirical calibration is needed to correct p-values.

Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Schuemie MJ, et al. Among authors: ryan pb. Stat Med. 2014 Jan 30;33(2):209-18. doi: 10.1002/sim.5925. Epub 2013 Jul 30. Stat Med. 2014. PMID: 23900808 Free PMC article.

10

Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature.

Schuemie MJ, Ryan PB, Suchard MA, Shahn Z, Madigan D. Schuemie MJ, et al. Among authors: ryan pb. Biostatistics. 2014 Jan;15(1):36-9; discussion 39-45. doi: 10.1093/biostatistics/kxt037. Epub 2013 Sep 25. Biostatistics. 2014. PMID: 24068252 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page